Receiving an mRNA COVID-19 vaccine within 100 days of starting ICI therapy may improve overall survival in some patients with cancer.

For patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy compared with ipilimumab monotherapy.

COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common.

Advancements in laser technologies for skin rejuvenation in various skin conditions was shown to be safe, efficacious, and satisfactory to patients.

Treatment with baloxavir marboxil significantly reduced the risk of onward transmission of influenza within households.

The US Vaccines for Children program has prevented millions of cases of illness, hospitalizations, and deaths, resulting in massive direct and societal savings.

Surgery was the most effective treatment for cutaneous squamous cell carcinoma in situ, however, variations among other treatment approaches exist.